Goldberg Caren S, Lu Minmin, Sleeper Lynn A, Mahle William T, Gaynor J William, Williams Ismee A, Mussatto Kathleen A, Ohye Richard G, Graham Eric M, Frank Deborah U, Jacobs Jeffrey P, Krawczeski Catherine, Lambert Linda, Lewis Alan, Pemberton Victoria L, Sananes Renee, Sood Erica, Wechsler Stephanie B, Bellinger David C, Newburger Jane W
University of Michigan Medical School and CS Mott Children's Hospital, Ann Arbor, MI.
New England Research Institute, Watertown, MA.
J Pediatr. 2014 Sep;165(3):490-496.e8. doi: 10.1016/j.jpeds.2014.05.019. Epub 2014 Jun 19.
To measure neurodevelopment at 3 years of age in children with single right-ventricle anomalies and to assess its relationship to Norwood shunt type, neurodevelopment at 14 months of age, and patient and medical factors.
All subjects in the Single Ventricle Reconstruction Trial who were alive without cardiac transplant were eligible for inclusion. The Ages and Stages Questionnaire (ASQ, n = 203) and other measures of behavior and quality of life were completed at age 3 years. Medical history, including measures of growth, feeding, and complications, was assessed through annual review of the records and phone interviews. The Bayley Scales of Infant Development, Second Edition (BSID-II) scores from age 14 months were also evaluated as predictors.
Scores on each ASQ domain were significantly lower than normal (P < .001). ASQ domain scores at 3 years of age varied nonlinearly with 14-month BSID-II. More complications, abnormal growth, and evidence of feeding, vision, or hearing problems were independently associated with lower ASQ scores, although models explained <30% of variation. Type of shunt was not associated with any ASQ domain score or with behavior or quality-of-life measures.
Children with single right-ventricle anomalies have impaired neurodevelopment at 3 years of age. Lower ASQ scores are associated with medical morbidity, and lower BSID-II scores but not with shunt type. Because only a modest percentage of variation in 3-year neurodevelopmental outcome could be predicted from early measures, however, all children with single right-ventricle anomalies should be followed longitudinally to improve recognition of delays.
测量单右心室异常患儿3岁时的神经发育情况,并评估其与诺伍德分流类型、14个月时的神经发育以及患者和医学因素之间的关系。
单心室重建试验中所有存活且未接受心脏移植的受试者均符合纳入标准。在3岁时完成了年龄与发育进程问卷(ASQ,n = 203)以及其他行为和生活质量测量。通过每年审查记录和电话访谈评估病史,包括生长、喂养和并发症的测量。14个月时的贝利婴儿发展量表第二版(BSID-II)得分也作为预测指标进行评估。
每个ASQ领域的得分均显著低于正常水平(P <.001)。3岁时的ASQ领域得分与14个月时的BSID-II呈非线性变化。更多的并发症、生长异常以及喂养、视力或听力问题的证据与较低的ASQ得分独立相关,尽管模型解释的变异不足30%。分流类型与任何ASQ领域得分或行为或生活质量测量均无关联。
单右心室异常患儿在3岁时神经发育受损。较低的ASQ得分与医学发病率相关,与较低的BSID-II得分相关,但与分流类型无关。然而,由于早期测量只能预测3岁神经发育结果中适度比例的变异,因此所有单右心室异常患儿都应进行纵向随访,以提高对发育迟缓的识别。